跳至主要内容
临床试验/NCT04483427
NCT04483427Unknown不适用

Multimodal Postoperative Analgesia Using Accufuser for Multilevel Surgery for Obstructive Sleep Apnea (OSA)

Bahaa Mohammed Refaie2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年9月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
Postoperative pain

研究概览

简要总结

Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser) for postoperative analgesia following multilevel OSA surgeries

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • physical status of American Society of Anesthesiologists (ASA) II
  • age between 30 - 50 years
  • OSA patients diagnosed by polysomnography and stop-bang questionnaire
  • enrolled for multilevel OSA surgery

排除标准

  • history of allergy to the study drugs
  • history of hepatic, cardiopulmonary or renal disease
  • history of any chronic pain on medication
  • history of substance abuse
  • psychiatric disorder
  • lack of patient cooperation.

结局指标

主要结局

Postoperative pain

时间窗: Assessment will be carried out 48 hours postoperatively

Visual analog pain score

次要结局

  • Sedation level(48 hours postoperatively)
  • incidence of adverse effects(48 hours postoperatively)

研究者

发起方
Bahaa Mohammed Refaie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bahaa Mohammed Refaie

Lecturer of anesthesia and ICU

Sohag University

研究点 (2)

Loading locations...

相似试验